1 It has been suggested that the tachycardic response to 5-hydroxytryptamine (5-HT) in the spinaltransected cat is mediated by`5-HT 1 -like' receptors since this eect, being mimicked by 5-carboxamidotryptamine (5-CT), is not modi®ed by ketanserin or MDL 72222, but it is blocked by methiothepin, methysergide or mesulergine. The present study was set out to reanalyse this suggestion in terms of the IUPHAR 5-HT receptor classi®cation schemes proposed in 1994 and 1996. ), ergotamine (100 and 300 mg kg 71 ) or mesulergine (100, 300 and 1000 mg kg 71 ); the highest doses of these antagonists used also blocked the tachycardic eects of 5-CT. Clozapine (1000 and 3000 mg kg 71 ) did not aect the 5-HT-induced tachycardia, but attenuated, with its highest dose, the responses to 5-methoxytryptamine and 5-CT. However, these doses of clozapine as well as the high doses of ergotamine (300 mg kg
Introduction 5-Hydroxytryptamine (5-HT) elicits complex changes in the cardiovascular system comprising bradycardia or tachycardia, hypotension or hypertension and vasodilatation or vasoconstriction (for reviews, see Saxena & VillaloÂ n, 1990; . In most species, bradycardia induced by 5-HT is mediated by 5-HT 3 receptors, via the activation of the von Bezold Jarisch re¯ex; in marked contrast, 5-HT-induced tachycardia is notoriously species-dependent and is mediated, directly or indirectly, either by`5-HT 1 -like' (cat), 5-HT 2 (rat, dog), 5-HT 3 (rabbit, dog) and 5-HT 4 (pig, human) receptors or by tyramine-like (guinea-pig) or unidenti®ed mechanisms (Saxena, 1986; Saxena & VillaloÂ n, 1990; .
The so called`5-HT 1 -like' receptors mediating tachycardia in the cat are potently stimulated by 5-carboxamidotryptamine (5-CT) and blocked by methiothepin and methysergide Saxena, 1988) . However, it is noteworthy that these receptors do not satisfactorily ful®ll some classi®cation requirements for the 5-HT 1 type, including insensitivity to stimulating doses of RU 24969 and 8-OH-DPAT at typical 5-HT 1 -like receptor-mediated responses (e.g. constriction of porcine carotid arteriovenous anastomoses; Saxena & VillaloÂ n, 1990) , blockade by mesulergine (Saxena, 1988) , an ergoline devoid of interactions with the 5-HT 1 receptor family (Hoyer et al., 1994) , and inconsistency with a negative coupling to adenylyl cyclase (Hoyer et al., 1994) . These cardiac receptors, consequently, are dierent from the typical 5-HT 1 -like receptors mediating vasoconstriction, a response usually associated with a decrease in cyclic AMP (Sumner et al., 1992) , but are similar to those mediating direct relaxation of vascular and non-vascular smooth muscle, a response that involves an increase in cyclic AMP (for references see Saxena & VillaloÂ n, 1990; Martin, 1994) .
While evidence is emerging that sumatriptan-sensitive 5-HT 1 -like receptors mediating vasoconstriction resemble 5-HT 1Db/1Da receptors (De Vries et al., 1996; VillaloÂ n et al., 1996) , presently known as a 5-HT 1B/1D receptors (Hartig et al., 1996) , the recently cloned 5-ht 7 receptor (e.g. Bard et al., 1993; Ruat et al., 1993) seems to be a suitable candidate for responses mediated by the atypical, sumatriptan-insensitive 5-HT 1 -like receptors. Indeed, the cloned 5-ht 7 receptor is positively coupled to adenylyl cyclase and binding studies show that the cloned 5-ht 7 receptor displays high anities for 5-CT, 5-HT, methiothepin, mesulergine and methysergide, but relatively low anities for RU 24969, 8-OH-DPAT and sumatriptan (Hoyer et al., 1994) .
In the light of these ®ndings, the present study was set out to investigate the operational characteristics of the 5-HT receptors mediating tachycardia in the spinal cat, with particular emphasis on verifying if these receptors display the pharmacological pro®le of the cloned 5-ht 7 receptor. Hence, the drugs employed included agonists and/or antagonists at 5-HT 1 , 5-HT 2 , 5-HT 3 and 5-HT 4 receptors, as well as some compounds with high anity for the cloned 5-ht 5 , 5-ht 6 and/or 5-ht 7 receptors (see Hoyer et al., 1994) .
Methods

General
Forty one cats of either sex, not selected for breed (2.5 ± 4.0 kg) were fasted overnight and initially anaesthetized with sodium pentobarbitone (30 mg kg 71 , i.v.) . Left femoral vein and artery were cannulated for, respectively, drug injections and the measurement of aortic blood pressure by a Statham pressure transducer (P23 ID). Heart rate was obtained by triggering a tachograph (Grass Instruments Co., Quincy, MA, USA; model 7P4) with the ECG signals. Blood pressure and heart rate were recorded simultaneously by a model 7D Grass polygraph (Grass Instrument Co., Quincy, MA, U.S.A.). The animals were then given an additional dose of pentobarbitone (10 ± 15 mg kg 71 , i.v.) and intubated with an endotracheal tube for arti®cial ventilation with room air, by a Palmer ventilation pump (rate: 20 strokes min
71
; stroke volume: 13 ± 16 ml kg
). Subsequently, both vagosympathetic trunks and the spinal cord (at the level of C 1 ± C 2 ) were sectioned in all animals, as previously described Saxena, 1988) .
Experimental protocols
After the cats had been in a stable haemodynamic condition for at least 60 min, baseline values of blood pressure and heart rate were determined. Then, the animals were divided into two groups.
The ®rst group (n=34) received consecutive i.v. bolus injections, every 5 to 10 min, of 5-HT (3, 10 and 30 mg kg 71 ), 5-methoxytryptamine (3, 10 and 30 mg kg 71 ) and isoprenaline (0.01, 0.03 and 0.1 mg kg 71 ) and the changes produced in blood pressure and heart rate were noted. At this point, the animals were divided into six subgroups. Four subgroups were treated, by use of a cumulative dose schedule, with either physiological saline (0.1 and 0.3 ml kg 71 ; n=5), lisuride (30 and 100 mg kg
71
; n=6), ergotamine (100 and 300 mg kg 71 ; n=6) or mesulergine (100, 300 and 1000 mg kg 71 ; n=6). The ®fth subgroup (n=6) was given clozapine (1000 and 3000 mg kg
) following a sequential (not cumulative) dosing because it produced an immediate short-lasting tachycardic response by itself. The sixth subgroup (n=5) was treated with GR127935 (500 mg kg 71 ) and, subsequently, with tropisetron (3000 mg kg 71 ). The responses to i.v. injections of 5-HT, 5-methoxytryptamine and isoprenaline, at the doses and sequence listed above, were elicited again 10 min after each dose of physiological saline or the above compounds.
The second group (n=7) received consecutive i.v. injections of 5-HT (3, 10 and 30 mg kg
) and isoprenaline (0.01, 0.03 and 0.1 mg kg
) and the changes in blood pressure and heart rate were noted. The animals were then divided into two subgroups. The ®rst subgroup (n=4) was given, sequentially, i.v. injections of the 5-HT 1 receptor agonist, indorenate (300 and 1000 mg kg 71 spaced by 5 min) followed by the 5-HT 4 receptor (partial) agonist, cisapride (300 and 1000 mg kg 71 spaced by 5 min) and the second subgroup (n=3) was treated with sequential i.v. injections of the 5-HT 1 receptor agonist, sumatriptan (30, 100 and 300 mg kg 71 spaced by 5 min). After each treatment and dose, the responses to 5-HT and isoprenaline were reanalysed.
Subsequently, each of the above 8 subgroups received, at the end of their corresponding protocol, i.v. injections of 5-CT at cumulative total dose levels of 0.03, 0.1, 0.3, 1, 3, 10 and 30 mg kg 71 every 5 ± 7 min. The changes in heart rate and blood pressure, produced after each dose of 5-CT, were noted. Lastly, in at least three cats of each of the above eight subgroups (see Results section), the highest dose used of saline or the corresponding drug was administered once again in an attempt to investigate which compounds could reverse the tachycardia elicited by the highest dose of 5-CT (30 mg kg 71 ), as previously described for methysergide .
With the exception of 5-CT (see above), the dose-intervals between the dierent doses of agonists ranged between 1 and 10 min, as in each case we waited until the heart rate had returned to baseline values. For the antagonists, as well as for indorenate, cisapride and sumatriptan, a period of 10 min was allowed to elapse before the dose-response curves for the agonists were elicited again. The dosing with 5-HT, 5-methoxytryptamine, isoprenaline, sumatriptan, indorenate, cisapride and clozapine was sequential, whilst that for 5-CT and the rest of the antagonists was cumulative.
Data presentation and statistical analysis
All data in the text and ®gures are presented as mean+s.e.-mean and these were analysed by a computer programme (Saxena, 1985) . The agonist-induced increases in heart rate just before and after a particular dose of saline or antagonist drug within one group of animals were compared by Student Newman-Keuls' test, once an analysis of variance (randomized block design) had revealed that the samples represented different populations. Furthermore, the increases in heart rate by 5-HT and isoprenaline before and after sumatriptan (430 mg kg 71 ), indorenate (1300 mg kg
71
) or cisapride (1300 mg kg 71 ), given cumulatively, were compared by using paired Student's t test. Finally, the tachycardic responses to 5-CT in the dierent groups of animals were compared by using unpaired Student's t test. A P value of 0.05 or less (two-tailed) was considered statistically signi®cant.
Drugs
Apart from the anaesthetic (sodium pentobarbitone), the drugs used in the present study (obtained from the sources indicated) were the following: 5-hydroxytryptamine creatinine sulphate 
Results
Initial blood pressure and heart rate changes by 5-HT receptor agonists
Baseline values of mean arterial blood pressure and heart rate in the forty one cats were, respectively, 84+3 mmHg and 184+35 beats min
71
. The changes induced in mean arterial blood pressure by the agonist drugs were: 5-HT (72+1, +3+4 and +15+5 mmHg after 3, 10 and 30 mg kg 71 , respectively; n=41), 5-methoxytryptamine (71+2, +7+4 and +23+4 mmHg after 3, 10 and 30 mg kg 71 , respectively; n=34), 5-CT (71+17, 713+5, 717+6 and 720+7 mmHg after 0.03, 0.1, 0.3 and 1 mg kg 71 , with 3, 10 and 30 mg kg 71 producing no subsequent change; n=5, i.e. saline-treated animals), sumatriptan (712+12, +17+9, +3+2 mmHg after 30, 100 and 300 mg kg 71 , respectively; n=3), indorenate (75+7 and 73+5 mmHg after 300 and 1000 mg kg 71 , respectively; n=4), cisapride (71+2 and 77+3 mmHg after 300 and 1000 mg kg 71 , respectively; n=4) and clozapine (79+5 and 718+5 mmHg after 1000 and 3000 mg kg 71 , respectively; n=6). It should be pointed out that these eects were not evaluated further because in spinal cats the baseline blood pressure is low and, consequently, the hypotensive responses produced by the above agonists were smaller and not strictly dose-dependent (see above).
The onset of the increases in heart rate induced by the agonists under study was immediate. Figure 1 shows that isoprenaline, 5-CT, 5-HT, 5-methoxytryptamine and clozapine caused dose-dependent increases in heart rate; in contrast, sumatriptan, indorenate and cisapride, at the doses tested, failed to increase feline heart rate. Isoprenaline was about 1.5 log units more potent than 5-CT, which was itself distinctly more potent (1.5 log units) than 5-HT and 5-methoxytryptamine; clozapine was the least potent. Thus, the apparent rank order of agonist potency was: isoprenaline 44 5-CT 44 5-HT4 5-methoxytryptamine 44 clozapine.
The duration of tachycardic eects of agonist drugs (except 5-CT) was relatively short: isoprenaline (3.9+0.2, 4.8+0.2 and 6.2+0.2 min after 0.01, 0.03 and 0.1 mg kg 71 , respectively), 5-HT (2.6+0.2, 4.6+0.2 and 7.0+0.3 min after 3, 10 and 30 mg kg 71 , respectively), 5-methoxytryptamine (2.3+0.2, 3.5+0.2 and 5.2+0.2 min after 3, 10 and 30 mg kg 71 , respectively) or clozapine (2.1+1.0 and 3.0+1.0 after 1000 and 3000 mg kg 71 , respectively). Furthermore, the 5-CT-induced tachycardia has been shown to last longer than 1 h Saxena, 1988) and, therefore, as expected, no recovery was observed with 5-CT during the dosing intervals (5 ± 7 min) or for at least 10 min after the last dose.
Eect of physiological saline and 5-HT receptor antagonists on the tachycardic responses induced by 5-HT, 5-methoxytryptamine and isoprenaline
The eects of physiological saline or lisuride on the tachycardic responses induced by 5-HT, 5-methoxytryptamine and isoprenaline are depicted in Figure 2 . No evidence of tachyphylaxis was observed since the responses to these agonists, at the doses and time intervals (330 min) used in the present study, were reproducible and remained essentially unchanged in control animals receiving two doses (0.1 and 0.3 ml kg 71 , i.v.) of physiological saline (Figure 2a ). In contrast, the administration of low doses (30 and 100 mg kg
, i.v.) of lisuride potently and dose-dependently antagonized the tachycardic responses induced by 5-HT and 5-methoxytryptamine; this blockade was speci®c as lisuride did not alter isoprenaline-induced tachycardia (Figure 2b ). Ergotamine (100 and 300 mg kg 71 ) and mesulergine (100, 300 and 1000 mg kg 71 ) also produced a dose-dependent blockade of the tachycardic responses to 5-HT and 5-methoxytryptamine (Figure 3a and b, respectively) . However, the blockade produced by the high doses of ergotamine (300 mg kg 71 ) and mesulergine (300 and 1000 mg kg 71 ) was not speci®c as they also attenuated the tachycardic eects of isoprenaline (Figure 3a and b) . Moreover, the atypical antipsychotic drug, clozapine (1000 and 3000 mg kg 71 ), did not aect 5-HT-induced tachycardia, but signi®cantly blocked, at its highest dose, the responses to 5-methoxytryptamine. However, these doses of clozapine also attenuated the tachycardic eects of isoprenaline (Figure 4a) .
The apparent order of potency for blockade of both 5-HTand 5-methoxytryptamine-induced tachycardic responses was ergotamine 5 lisuride 4 mesulergine 4 clozapine. Finally, as shown in Figure 4b , the tachycardic responses to 5-HT, 5-methoxytryptamine and isoprenaline were not signi®cantly modi®ed after administration of the selective 5-HT 1B/1D receptor antagonist, GR127935 (Skingle et al., 1996) or by the subsequent administration of tropisetron which, at 3000 mg kg
, is a 5-HT 3 and 5-HT 4 receptor antagonist (VillaloÂ n et al., 1990b; .
Except for an immediate and sustained increase in mean blood pressure by ergotamine (from 103+9 to 134+13 mmHg, after its highest dose; P50.05), the values of mean blood pressure and heart rate before and 10 min after the administration of physiological saline or the above 5-HT receptor antagonists were not signi®cantly dierent (data not shown).
Tachycardic eects of 5-HT before and after administration of indorenate, cisapride or sumatriptan
Since the 5-HT receptor agonists, indorenate, cisapride and sumatriptan, failed to mimic 5-HT in increasing heart rate (see Figure 1) , we decided to investigate these compounds (1300 mg kg 71 each of indorenate and cisapride in one subgroup and 430 mg kg 71 of sumatriptan in another subgroup) as potential antagonists of the tachycardic responses to 5-HT. 5-HT (3, 10 and 30 mg kg 71 ) elicited a dose-dependent tachycardia (®rst subgroup: 5+2, 26+10 and 46+11 beats min 71 , n=4, respectively; second subgroup: 7+2, 17+6 and 43+7 beats min 71 , n=3, respectively). These responses as well as the tachycardia elicited by isoprenaline (0.01, 0.03 and 0.1 mg kg 71 ) remained unaected after administration of the above compounds (data not shown). Tachycardic eects of 5-CT after physiological saline or some compounds acting at 5-HT receptors After the tachycardic response to 30 mg kg 71 5-CT (given cumulatively) had been stable for at least 10 min, a subsequent administration of the same dose of saline, GR127935+tropisetron, indorenate+cisapride or sumatriptan (n=3 each) in the corresponding subgroups produced no further change in heart rate (data not shown). In contrast, 5-CT-induced tachycardia was signi®cantly (P50.05) decreased from the prevailing values after i.v. administration of the same dose of lisuride (717+1%; n=4), ergotamine (78+2%; n=4), clozapine (722+4%; n=3) or mesulergine (725+2%; n=6).
Discussion
In previous studies, had proposed that the tachycardia induced by 5-HT in the cat, being potently mimicked by 5-CT and blocked by methysergide, is mediated bỳ 5-HT 1 -like' receptors on the basis of the resistance to blocking doses of antagonists at 5-HT 2 (ketanserin, ritanserin) and 5-HT 3 (MDL 72222) receptors. However, it is noteworthy that, in contrast to its constrictor eects via vascular 5-HT 1 -like receptors (see Saxena & VillaloÂ n, 1990 ), methysergide did not show any agonist activity at the feline cardiac`5-HT 1 -like'
receptors. Subsequently, Saxena (1988) showed that these atypical cardiac receptors were unrelated to the 5-HT 1A , 5-HT 1B , 5-HT 1C (now 5-HT 2C ) and 5-HT 1D subtypes based on: (i) the blockade, in decreasing order of potency, by methiothepin, mesulergine and metergoline (an order which does not match with their corresponding anities for these receptors; Hoyer, 1988) ; (ii) the low agonist potency of the 5-HT 1A receptor agonist, 8-OH-DPAT; and (iii) the lack of activity of 5-HT 1A/1B receptor agonist, RU 24969. Certainly, the approach established by the IUPHAR 5-HT receptor classi®cation scheme (Hoyer et al., 1994) lead us to conclude that the appellation`5-HT 1 -like' is no longer regarded as appropriate for the 5-HT receptors mediating tachycardia in the cat. The operational approach of the present study strengthens this view, as the feline cardiac 5-HT receptors were not stimulated by sumatriptan or indorenate (both agonists at typical 5-HT 1 -like receptors mediating vasoconstrictor responses; Saxena & VillaloÂ n, 1990; VillaloÂ n et al., 1990a; Hoyer et al., 1994) and could be blocked by a series of drugs showing high anity for cloned 5-ht 7 receptors. Thus, these cardiac receptors resemble those mediating smooth muscle relaxation and elevation of adenosine 3':5'-cyclic monophosphate (cyclic AMP) in neonatal porcine vena cava (Trevithick et al., 1986; Sumner et al., 1989) , hypotension in anaesthetized rats (Saxena & Lawang, 1985; De Vries et al., 1997) and cats (Connor et al., 1986) and vasodilatation in the canine external carotid bed (VillaloÂ n et al., 1997).
Apart from the implications discussed below, these data suggest that the 5-HT receptors mediating tachycardia in the cat may represent a functional correlate of the recombinant 5-ht 7 receptor.
Agonist action of some tryptamine derivatives on the feline heart 5-HT receptor Admittedly, the rank order of agonist potency (5-CT 44 5-HT45-methoxytryptamine) observed in our study is similar to that found for the prejunctional sympatho-inhibitory 5-HT 1B/1D receptors mediating canine external carotid vasodilatation (VillaloÂ n & TerroÂ n, 1994) . Nevertheless, at these prejunctional 5-HT 1B/1D receptors, indorenate and sumatriptan behaved as agonists (VillaloÂ n et al., 1993; VillaloÂ n & TerroÂ n, 1994) , as previously shown for other 5-HT 1B/1D receptors (Saxena & VillaloÂ n, 1990; VillaloÂ n et al., 1990a; 1996; De Vries et al., 1996) . Contrasting with this 5-HT 1B/1D receptor operational pro®le, our results in the cat heart clearly showed that sumatriptan and indorenate did not behave as agonists (or antagonists). The above rank order of agonist potency, therefore, closely resem- Figure 4 Eects of bolus injections of (a) clozapine (n=6) or (b) GR127935 (n=5) followed by tropisetron (n=5) on tachycardic responses to 5-HT, 5-methoxytryptamine (5-MeO-T) and isoprenaline in vagosympathectomized spinal cats. HR, heart rate. *P50.05 vs the corresponding control response.
bles the pharmacological properties of the cloned 5-ht 7 receptor subtype; pK D values obtained for recombinant 5-ht 7 receptors for 5-CT, 5-HT, 5-methoxytryptamine and sumatriptan are 9.5, 8.7, 8.8 and 6.2, respectively (Hoyer et al., 1994) .
Do feline heart 5-HT receptors correlate with any subtype of the 5-HT 1 receptor family?
Although the above rank order of agonist potency with indorenate and sumatriptan already excludes the involvement of 5-HT 1A , 5-HT 1B/1D and sumatriptan-sensitive 5-HT 1 -like receptors, it is well known that the 5-HT 1 receptor family includes two additional subtypes, namely, the cloned 5-ht 1E and 5-ht 1F receptors (Hoyer et al., 1994) . However, the involvement of these subtypes in the present study is unlikely because (i) 5-CT and 5-methoxytryptamine, which display very low anity for the recombinant 5-ht 1E and 5-ht 1F receptors (Adham et al., 1993; Hoyer et al., 1994) , potently mimicked 5-HT in eliciting tachycardia; (ii) the tachycardic responses to 5-CT, 5-HT and 5-methoxytryptamine were antagonized by mesulergine and clozapine, which do not interact with any subtype of the 5-HT 1 receptor family (Hoyer et al., 1994) ; (iii) these tachycardic responses were not antagonized by GR127935 at doses that are high enough to block 5-HT 1B/1D receptors (De Vries et al., 1996; Skingle et al., 1996; VillaloÂ n et al., 1996) and (iv) the 5-HT 1 receptor family is, by de®nition, negatively coupled to adenylyl cyclase (Hoyer et al., 1994) , a signal transduction system usually associated with vasoconstriction and bradycardia, not tachycardia (Rand et al., 1987; Saxena & VillaloÂ n, 1990; Sumner et al., 1992) .
Lack of resemblance of the feline heart 5-HT receptor with either 5-HT 2 , 5-HT 3 , 5-HT 4 , 5-ht 5 or 5-ht 6 receptors
The 5-HT receptors mediating tachycardia in the cat also seem to dier from the 5-HT 2 , 5-HT 3 , 5-HT 4 and 5-ht 6 receptor types on the basis of: (i) the high potency of 5-CT relative to 5-HT (present results), an order which is reversed for the aforementioned types (Hoyer et al., 1994) ; (ii) insensitivity to antagonism by high doses of 5-HT 2 (ketanserin, ritanserin or cyproheptadine) and 5-HT 3 (MDL 72222) receptor antagonists ; (iii) the inactivity (as agonist or antagonist) of cisapride (present study), a benzamide with partial agonist properties at the 5-HT 4 receptors mediating tachycardia in the pig (VillaloÂ n et al., 1991); (iv) resistance to antagonism by tropisetron at doses (3000 mg kg 71 ) that block 5-HT 3 and 5-HT 4 receptors (VillaloÂ n et al., 1990b; and (v) the potent blockade by mesulergine, a compound showing an almost 300 fold selectivity for the cloned 5-ht 7 receptor (pK D =8.2) over the cloned 5-ht 6 receptor (pK D =5.8) (Hoyer et al., 1994) . Furthermore, based on the above ®ndings, the ability of 5-methoxytryptamine to induce tachycardia in the cat, which is, in its own right, an additional criterion to exclude the participation of 5-HT 3 receptors (Hoyer et al., 1994) , cannot be attributed to its agonist properties at 5-HT 4 receptors (VillaloÂ n et al., 1991) .
Interestingly, 5-CT (pK D : 9.5 and 7.4, respectively), methiothepin (pK D : 7.0 and 7.8, respectively) and ergotamine (pK D : 8.4 and 8.5, respectively) display a relatively high anity for the recombinant 5-ht 5A and 5-ht 5B receptors (Hoyer et al., 1994) . This, therefore, raises the question whether the cloned 5-ht 5A/5B receptors are related to the 5-HT receptors mediating tachycardia in the cat. However, this does not seem very likely because: (i) ergotamine failed to increase heart rate in the cat (present results) and (ii) methiothepin, which has a ten fold lower anity than ergotamine for 5-ht 5A/5B receptors (see above), was more potent (not less potent as may be expected from their anities for 5-ht 5A/5B receptors) than ergotamine in blocking 5-HT-induced feline tachycardia (Saxena, 1988; present results) . Moreover, the antagonism by mesulergine (present results) and metergoline (Saxena, 1988) , both with pK D values of 56.0 at cloned 5-ht 5A/5B receptors (Hoyer et al., 1994) , also points against these receptors mediating the 5-HTinduced tachycardia in the cat.
Resemblance of the feline heart 5-HT receptor to putative 5-HT 7 receptors
Since the involvement of 5-HT 1 -5-ht 6 receptors seems improbable, the possibility has ®nally to be discussed that the 5-HT receptors mediating tachycardia in the cat resemble the cloned 5-ht 7 receptor. Indeed, the rank order of agonist potency of 5-CT 44 5-HT45-methoxytryptamine 44 clozapine to produce tachycardia in the cat, with sumatriptan and indorenate inactive (present results) parallels that obtained with the mouse (Lovenberg et al., 1993; Plassat et al., 1993) , rat (Ruat et al., 1993; Shen et al., 1993) and human (Bard et al., 1993) cloned 5-ht 7 receptors (5-CT45-methoxytryptamine 5 5-HT). Signi®cantly, the above rank order of agonist potency is practically identical to that found in other preparations where the relaxant eects of 5-HT have been ascribed to stimulation of musculotropic 5-HT 7 -like receptors; some of these preparations include the rabbit femoral vein (Martin & Wilson, 1995) , the Cynomolgus monkey isolated jugular vein (Leung et al., 1996) , the guinea-pig ileum (Carter et al., 1995) and the canine coronary (TerroÂ n, 1996) and external carotid (VillaloÂ n et al., 1997) arteries.
This suggestion is further strengthened when considering that the tachycardia induced by 5-HT in the cat was blocked in previous studies (Saxena, 1988) by methiothepin (pK D : 9.0), methysergide (pK D : 7.9) and metergoline (pK D : 8.7), compounds that display high anities for cloned 5-ht 7 receptors (Hoyer et al., 1994) . On this basis, in the present study, we deliberately selected ergotamine, lisuride, clozapine and mesulergine as potential antagonists because they show either high anity (the former three) or relative selectivity (the latter) for the cloned 5-ht 7 receptor (see Hoyer et al., 1994) . Accordingly, all of these compounds blocked the 5-CT-, 5-HTand 5-methoxytryptamine-induced tachycardic responses, though this blockade appeared to be highly speci®c only for lisuride. Indeed, ergotamine, lisuride, mesulergine or clozapine have been shown to antagonize smooth muscle relaxant responses mediated by other functional 5-HT 7 receptors (e.g. Carter et al., 1995; Martin & Wilson, 1995; TerroÂ n, 1996; VillaloÂ n et al., 1997) .
Admittedly, there are no selective agonists and antagonists at cloned 5-ht 7 receptors available so far. Thus, although we recognize that the antagonists blocking 5-HT-induced feline tachycardia display varying degrees of anity for receptors other than 5-HT, including a (a 1 and a 2 )-adrenoceptors, H 2 histamine and muscarinic receptors (Leysen, 1985) , the agonists used in the present study do not interact with these receptors; most signi®cantly, these and other mechanisms in 5-HT-induced feline tachycardia (including stimulation of cardiac b-adrenoceptors and the indirect release of catecholamines) have already been excluded .
In conclusion, it is suggested that the tachycardic eect of 5-HT in the cat is mediated by a receptor similar to the cloned 5-ht 7 subtype. Since this cardiac 5-HT receptor represents another functional correlate of the 5-ht 7 gene product, the change of the appellation 5-ht 7 for 5-HT 7 is favoured. Although species variations should not be dismissed (Saxena & VillaloÂ n, 1991) , the present ®ndings in the cat seem to be the ®rst to show a tachycardic eect being mediated by the 5-HT 7 receptor. This in vivo experimental model, which is not complicated by the presence of other 5-HT receptors, can be utilized to characterize and develop, including the possibility of studying oral absorption, new drugs with potential agonist and antagonist properties at functional 5-HT 7 receptors.
